Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 13 - Drugs for disorders of the urinary system
Patents for A61P 13 - Drugs for disorders of the urinary system (56,135)
11/2009
11/24/2009CA2203182C Remedy for diseases caused by il-6 production
11/19/2009WO2009140137A1 Naphthylmethylimidizoles for the treatment of stress urinary incontinence
11/19/2009WO2009140078A1 Treatment of lower urinary tract dysfunction with cb2-receptor-selective agonists
11/19/2009WO2009139470A1 Pharmaceutical composition for treatment of fibromyalgia
11/19/2009WO2009139373A1 Amide compound
11/19/2009WO2009139361A1 Glucocorticoid receptor agonist composed of 2,2,4-trimethyl-6-phenyl-1,2-dihydroquinoline derivative having substituted oxy group
11/19/2009US20090286868 2-Amino-2-oxoethyl trans-3-[5-(naphth-1-yl)-1,3-dioxan-2-yl]propyl carbamate; reacting the phenylcarbonate with 2-aminodioxane; fatty acid amido hydrolase (FAAH) inhibitors; analgesics; nervous system disorders; gastrointestinal disorders,; to name just a few
11/19/2009US20090286846 such as N-(1-Methyl-1H-indol-5-yl)-1-(3-trifluoromethylbenzyl)-1H-indole-2-carboxamide, for the treatment of of bladder hyperactivity, hyperreflexia or instability, incontinence, urgent urination, urinary incontinence, cystitis, renal colic, pelvic hypersensitivity, pelvic pain, asthma and cough
11/19/2009US20090286842 Naphthylmethylimidizoles as therapeutic agents
11/19/2009US20090286766 Azolecarboxamide derivative
11/19/2009US20090286742 polypeptides comprising amino acid sequences corresponding to, similar to or homologous to part of the amino acid sequence of neural thread proteins, used for treating unwanted cellular proliferations such as benign prostatatic hyperplasia, cancer, unwanted facial hair, warts and fatty tissues
11/19/2009US20090286736 using polypeptide comprising a membrane translocation domain and a NF- kappa B Essential Modulator (NEMO) binding sequence; comprising a NEMO binding domain (NBD)
11/19/2009US20090285914 Treating liver and urogenital disorders, particularly of the kidney; antifibrotic agents; oxidation resistance; cirrhosis;lower the amount of hydroxyproline in liver but increase the amount of hydroxyproline in kidney, suggesting to improve kidney functions
11/19/2009US20090285816 Albumin Fusion Proteins
11/19/2009CA2740029A1 Pharmaceutical composition for treatment of fibromyalgia
11/19/2009CA2724290A1 Naphthylmethylimidizoles for the treatment of stress urinary incontinence
11/19/2009CA2724077A1 Amide compound
11/19/2009CA2724055A1 Glucocorticoid receptor agonist comprising 2,2,4-trimethyl-6-phenyl-1,2 -dihydroquinoline derivatives having substituted oxy group
11/19/2009CA2720523A1 Treatment of bladder dysfunction using liposomal botulinum toxin
11/18/2009EP2119718A1 Macrocyclic compound
11/18/2009EP2119716A1 Aza-bridged-ring compound
11/18/2009EP2119702A1 Amide derivative
11/18/2009EP2119700A1 Benzylamine derivative or pharmaceutically acceptable acid addition salt thereof, and use thereof for medical purposes
11/18/2009EP2119438A1 Bone metabolism ameliorating agent
11/18/2009EP2118271A1 Muscle derived cells for the treatment of urinary tract pathologies and methods of making and using the same
11/18/2009EP1490064B1 Substituted pyridinones as modulators of p38 map kinase
11/18/2009EP1358172B1 Amino ceramide-like compounds and therapeutic methods of use
11/18/2009EP0760811B1 Imidazole derivatives as histamine receptor h3 modulators
11/18/2009EP0758904B1 Methods and compositions for the treatment of glomerulonephritis
11/18/2009CN101583627A Methods for reducing phosphate absorption
11/18/2009CN101579462A Medicine for treating prostatauxe and preparation method thereof
11/18/2009CN101579411A Medicinal dripping pill for treating prostatauxe
11/18/2009CN101579406A Traditional Chinese medicine for treating chronic glomerulonephritis uraemia
11/18/2009CN101579395A Traditional Chinese medicine for treating kidney weakness
11/18/2009CN100560589C Imidazoselenazole compounds and their use for prevention and/or treatment of diseases relative to protein aging
11/18/2009CN100560584C Benzoazolypiperazine derivatives having MGLUR1- and MGLUR5-antagonistic activity
11/18/2009CN100560136C Ferrite/bacille calmette-guerin vaccine/temperature sensing gel integration material and preparation thereof
11/18/2009CN100560107C Traditional Chinese medicine composition, its preparation and quality controlling means
11/18/2009CN100560094C Preparing art of cassia twig and Tuckahoe composition and use thereof
11/18/2009CN100560063C Pill preparation of 'Shen Bao', its preparation method and quality control method
11/17/2009US7618967 Indane compounds
11/17/2009US7618791 Detecting ligands that stimulate the proliferation and/or development of hematopoietic, lymphoid and myeloid cells
11/17/2009US7618633 Antibodies that bind CD40 and methods of treating cancer and enhancing immune responses
11/17/2009US7618629 Manipulation of cytokine levels using CD83 gene products
11/17/2009CA2522051C Diamine derivative, production process therefor and antioxidant
11/17/2009CA2393809C Heterocyclic dihydropyrimidines as potassium channel inhibitors
11/17/2009CA2336822C Method of treatment and pharmaceutical composition
11/17/2009CA2321198C 2-arylethyl-(piperidin-4-ylmethyl)amine derivatives as muscarinic receptor antagonists
11/17/2009CA2259583C Azolo triazines and pyrimidines
11/12/2009WO2009137428A2 Methods of determining renal function using technetium-99m tricarbonyl-nitrilotriacetic acid
11/12/2009WO2009136625A1 Cyclic amine-1-carboxylic acid ester derivative and pharmaceutical composition containing the same
11/12/2009WO2009136611A1 Glutathione production enhancer, prophylactic/therapeutic agent for diseases associated with lack of glutathione, and food, beverage and feed
11/12/2009WO2009136370A1 Parenteral supplement with traceelemξntsfor treatment of i. a. sirs, burns selenium-defenciencies
11/12/2009WO2008133344A3 Piperidine derivative and use thereof
11/12/2009US20090281164 RNA INTERFERENCE MEDIATED INHIBITION OF RESPIRATORY SYNCYTIAL VIRUS (RSV) EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
11/12/2009US20090281147 Method of treating of demyelinating diseases or conditions
11/12/2009US20090281128 Caspase inhibitors and uses thereof
11/12/2009US20090281091 Methods for modulating bladder function
11/12/2009US20090280178 Process for the Preparation of Sevelamer Hydrochloride and Formulation Thereof
11/12/2009CA2721815A1 Cyclic amine-1-carboxylic acid ester derivative and pharmaceutical composition containing the same
11/11/2009EP2114870A1 Synthetic ion channels
11/11/2009EP2114441A1 The use of alkaline phosphatase in the treatment of reduced renal function
11/11/2009EP2114411A2 Composition and method for protecting mitochondria
11/11/2009EP2114390A2 Methods for treating podocyte-related disorders
11/11/2009EP1372634B1 Use of fumaric acid amides
11/11/2009EP1364659B1 Remedies for urinary diseases comprising lpa receptor controlling agents
11/11/2009EP1315812B1 Modified polypeptides stabilized in a desired conformation and methods for producing same
11/11/2009EP1255726B1 (r)-2-aryl-propionamides, useful in the inhibition of il-8 induced chemiotaxis of neutrophils
11/11/2009EP1191943B1 Anti-allergic peptides
11/11/2009CN101574520A Methods of administering anti-TNF alpha antibodies
11/11/2009CN101574493A Chinese medicament for treating hyperplasia of prostate
11/11/2009CN101574488A Chinese medicament for treating urinary tract infection
11/11/2009CN101574487A Chinese medicament for treating chronic stranguria
11/11/2009CN101574458A Traditional Chinese medicine preparation for curing impotence due to kidney deficiency
11/11/2009CN101574449A Chinese medicament for treating senile acute and chronic prostatitis
11/11/2009CN101574446A Chinese medicament for treating acute cystitis
11/11/2009CN101574422A Medicine composition and preparation method thereof
11/11/2009CN101574360A Application of epimedin in preparing medicines for treating diseases where estrogen needs supplementing
11/11/2009CN100558899C Growth hormone fusion protein
11/11/2009CN100558744C Use of a recombinant erythropoietin having high activity and reduced side effects
11/11/2009CN100558741C 17alpha-alkyl-17beta-oxy-estratrienes and intermediates for the production thereof, and use of said 17alpha-alkyl-17beta-oxy-estratrienes for producing medicaments and pharmaceutical preparations
11/11/2009CN100558724C Sulphonic acid amide for regulating bast peptide activity and derivative thereof
11/11/2009CN100558717C Novel medicine
11/11/2009CN100558712C Therapeutic molecules and methods-1
11/11/2009CN100558685C Extract from the pods of lupin seeds containing lupeol
11/11/2009CN100558410C Nucleic acids, polypeptides, and methods for modulating apoptosis
11/11/2009CN100558377C Chinese medicine composition for treating renal failure and its prepn process
11/11/2009CN100558370C Adsorbent for oral administration
11/11/2009CN100558368C Method and material for treating immune diseases
11/11/2009CN100558359C Remedy for glomerular diseae
11/11/2009CN100558350C Improved transdermal delivery system
11/11/2009CN100558340C Use of gourd oil for inhibiting s alpha-reductase activity
11/10/2009US7615564 Such as N5-[1-(2-chlorobenzyl)tetrahydro-1H-3-pyrrolyl]-5-isoquinolylamine; Rho kinase inhibitors; hypertension, asthma, angina pectoris, cerebrovascular contraction, peripheral circulatory disorder, threatened premature birth, glaucoma, vision disorders, autoimmune diseases, chronic renal failure
11/10/2009US7615553 E.g., N,N-dimethyl,((5-(hydroxyaminocarbonyl)pyrimidin-2-yl)(piperazin-1,4-ylene)sulfonamide; bioavailability; oral administration; metabolic stability; side effect reduction; psoriasis; anticarcinogenic -proliferative, -arthritic, -inflammatory agent; gene therapy; genetic transcription potentiation
11/10/2009US7615548 Method to inhibit ischemia and reperfusion injury
11/10/2009US7615543 Complexes with C-reactive protein (CRP) molecules; rheumatoid arthritis, juvenile chronic (rheumatoid) arthritis, ankylosing spondylitis, psoriatic arthritis, systemic vasculitis, polymyalgia rheumatica, Reiter's disease, Crohn's disease and familial Mediterranean fever
11/10/2009CA2481482C Tropane derivatives as ccr5 modulators
11/10/2009CA2419887C Sulphur analogues of 21-hydroxy-6,19-oxidoprogesterone (21oh-6op) for treating excess of glucocorticoids
11/10/2009CA2411572C 4,5-dihydro-thiazo-2-ylamine derivatives and their use as no-synthase inhibitors
11/10/2009CA2186953C Progesterone antagonists for the production of pharmaceutical agents for the treatment of dysfunctional uterine bleeding
1 ... 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 ... 562